Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · June 14, 2022

Alternative Dosing of Exemestane in Postmenopausal Women With Early-Stage ER+ Breast Cancer

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
A randomized presurgical trial of alternative dosing of exemestane in postmenopausal women with early-stage ER-positive breast cancer.
J. Clin. Oncol 2022 May 26;40(suppl 16)abstr 519, A DeCensi, D Serrano, S Gandini, et al

Further Reading